MEDIA RELEASE-ZAMRA AND MCAZ SIGN MOU MEDIA RELEASE- Warning Against Illegal Selling, Purchasing, And Use of Ozempic MCAZ Initiates Class II Recall of Captopril 25mg Tablets Due to Quality Defect MEDIA RELEASE – MCAZ WARNS AGAINST MEDICINES ADVERTISEMENT MEDIA RELEASE- MCAZ ISSUES A CLASS II RECALL FOR A BATCH OF YAZ PLUS CONTRACEPTIVES DUE TO A QUALITY ISSUE MEDIA RELEASE- MCAZ TAKES PART IN GLOBAL CAMPAIGN FOR SAFER USE OF MEDICINES MEDIA RELEASE – MCAZ and BoMRA Strengthen Cooperation Through MoU Renewal MEDIA RELEASE – Cosmetic Regulations MEDIA RELEASE – MCAZ attains WHO Benchmarking Tool Maturity Level 3 MEDIA RELEASE – MCAZ Signs MoU with Belarus MEDIA RELEASE – Benylin Recall Statement MEDIA RELEASE – ZRP and MCAZ Operation-Karoi MEDIA RELEASE – ZRP and MCAZ Operation-Caledonia MCAZ DG’s New Year Message MEDIA RELEASE – MCAZ SIGNS MOU WITH SOUTH AFRICA HEALTH PRODUCTS REGULATOR -12 JANUARY 2024 PRESS STATEMENT – MCAZ CONFISCATES 450 BOTTLES OF ILLEGAL COUGH SYRUPS (BRONCLEER AND ADCO-SALTERPYN) AT OLD TRAFFORD FLATS, BELVEDERE, HARARE. PRESS STATEMENT – MCAZ TAKES A STAND AGAINST DRUG ABUSE PRESS STATEMENT- REGULATORY ALERT REGARDING UNAUTHORISED BUYING AND SELLING OF SPECIALLY RESTRICTED PREPARATIONS AND THALIDOMIDE PRESS STATEMENT – UNSAFE USE OF GLUTATHIONE AND INJECTABLE VITAMINS AS SKIN LIGHTENING AGENTS PRESS STATEMENT – SUBSTANDARD (CONTAMINATED) PAEDIATRIC MEDICINES IDENTIFIED IN WHO REGION OF AFRICA PRESS STATEMENT – 25TH ANNIVERSARY 2022 PRESS STATEMENT – ILLEGAL ADVERTISING AND SELLING OF SUPERLIFE TOTAL CARE (STC30) IN ZIMBABWE PRESS STATEMENT – SUBSTANDARD (CONTAMINATED) SYRUP MEDICINES IDENTIFIED IN WHO REGION OF AFRICA PRESS STATEMENT – APPOINTMENT OF SUBSTANTIVE DIRECTOR-GENERAL | 